FDA Inspection 1105217 — RiconPharma LLC
The FDA completed an inspection of RiconPharma LLC on Sep 13, 2019 in Denville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Denville, NJ (United States)
Additional Details
Bioanalytical BA/BE